Examkin

Psychiatry

814 questions

All types814Multiple choice418Multiple select68Matching191Ordering137
Question 741Question →

A 24-year-old woman comes to an urgent care clinic reporting a painful skin rash, sore throat, and a low-grade fever that began 48 hours ago. Her medical history is notable for bipolar I disorder. She has been stable on valproate for three years. Five weeks ago, her psychiatrist initiated a cross-taper to a new mood stabilizer due to the patient's concerns regarding ongoing weight gain and hair thinning. She has been taking both medications exactly as prescribed. Her temperature is 38.8°C (101.8°F), pulse is 108/min, and blood pressure is 110/70 mm Hg. Physical examination reveals a diffuse, tender, erythematous, macular rash that easily coalesces into large blisters. Gentle pressure on the skin causes the top layer of the epidermis to detach. There are multiple painful erosions on her buccal mucosa and lips. Which of the following pharmacokinetic interactions most likely contributed to this patient's current condition?

Show answer & explanation

Answer: Inhibition of UDP-glucuronosyltransferase by the established mood stabilizer

Answer

The correct answer is the inhibition of UDP-glucuronosyltransferase by the established mood stabilizer, as valproate significantly reduces the clearance of lamotrigine.
This patient presents with fever, mucosal erosions, and a blistering rash with a positive Nikolsky sign (epidermal detachment with gentle pressure), which is the classic presentation of Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN). In a patient with bipolar disorder who is being cross-tapered off valproate to a weight-neutral alternative, the newly initiated medication is almost certainly lamotrigine. Lamotrigine is highly efficacious for bipolar maintenance but carries a black box warning for severe, life-threatening rashes. The risk of SJS/TEN is significantly increased when lamotrigine is co-administered with valproate. Valproate is a potent inhibitor of UDP-glucuronosyltransferase (UGT), which is the primary hepatic enzyme responsible for the glucuronidation and elimination of lamotrigine. This pharmacokinetic interaction effectively doubles the half-life and serum concentration of lamotrigine. Consequently, when initiating lamotrigine in a patient already taking valproate, the starting dose must be halved and the titration schedule must be remarkably slower to prevent toxic lamotrigine levels and minimize the risk of SJS/TEN.

Step-by-Step Solution

1
Diagnose the patient's acute dermatologic presentation.
The patient has a blistering rash with mucosal involvement and a positive Nikolsky sign, indicating Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN).
Recognizing this life-threatening drug reaction is the first requirement to identify the inciting pharmacologic event.
2
Identify the new psychotropic medication initiated.
The new medication is most likely lamotrigine.
Lamotrigine is a weight-neutral mood stabilizer commonly used for bipolar disorder that carries a well-known black box warning for SJS/TEN.
3
Analyze the pharmacokinetic interaction between the patient's current medications.
Valproate (the established medication) inhibits UDP-glucuronosyltransferase (UGT), the enzyme responsible for clearing lamotrigine.
To determine why the patient developed toxicity despite taking the medications as prescribed, one must understand how valproate alters lamotrigine metabolism.

Key Concept

Valproate is a potent inhibitor of UDP-glucuronosyltransferase (UGT). When co-administered with lamotrigine, it roughly doubles lamotrigine's half-life, significantly increasing the risk of life-threatening rashes like Stevens-Johnson syndrome.
Estimated Time:1m 30s
Question 742Question →

A 34-year-old woman is evaluated in the outpatient clinic at the insistence of her brother. According to him, she has been exhibiting highly unusual behavior for the past 8 weeks. She frequently pauses mid-conversation as if listening to an unseen individual and claims that a foreign intelligence agency is monitoring her thoughts via microchips in her dental fillings. Her brother notes that her speech has become disjointed, frequently jumping between completely unrelated topics. These changes started exactly two months ago; prior to this, she was employed as a graphic designer and functioning independently, but she has since been fired due to erratic behavior. She does not report any periods of depressed mood, elevated energy, or changes in sleep patterns. Vital signs and laboratory studies are within normal limits. Which of the following features most accurately differentiates this patient's current psychiatric syndrome from schizophrenia?

Show answer & explanation

Answer: Duration of the clinical presentation

Answer

Duration of the clinical presentation
This patient presents with 8 weeks of active-phase psychotic symptoms (hallucinations, delusions, disorganized speech) alongside functional impairment, meeting the criteria for schizophreniform disorder. Schizophreniform disorder and schizophrenia share identical symptom criteria (Criterion A). The key differentiating feature between the two is the timeline: schizophreniform disorder lasts between 1 and 6 months, whereas a diagnosis of schizophrenia is made only after symptoms have persisted for 6 months or longer.

Step-by-Step Solution

1
Identify the patient's active psychiatric symptoms.
The patient exhibits auditory hallucinations, persecutory delusions, and disorganized speech.
These satisfy Criterion A for primary psychotic disorders.
2
Determine the exact duration of the psychotic symptoms.
The symptoms began exactly two months (8 weeks) ago.
Duration is the primary factor used to differentiate the three main primary psychotic disorders.
3
Correlate the symptom duration with the appropriate diagnosis.
Symptoms lasting between 1 month and 6 months indicate schizophreniform disorder.
Brief psychotic disorder lasts less than 1 month, while schizophrenia requires continuous signs of disturbance for at least 6 months.

Key Concept

The primary differentiating factor between brief psychotic disorder, schizophreniform disorder, and schizophrenia is the duration of symptoms.
Question 743Question →

A family brings their 3-year-old daughter to the pediatric clinic due to concerns regarding her speech. The parents report that over the last 6 weeks, the child has begun repeating syllables at the beginning of sentences, frequently saying phrases like "Ca-ca-can we go outside?" or "I-I-I see the dog." These repetitions primarily occur when the child is highly excited or fatigued. The patient does not appear frustrated by these speech patterns, maintains steady eye contact, and exhibits no facial grimacing or physical tension while speaking. Her vocabulary is expanding appropriately, and she regularly engages in imaginative, cooperative play with her older sibling. A recent audiological screening was unremarkable. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Reassurance and observation

Answer

Reassurance and observation
The correct answer is reassurance and observation. This patient is exhibiting normal developmental disfluency, which is highly common in children between the ages of 2 and 5 as their expressive language skills rapidly expand. It is characterized by the effortless repetition of syllables or whole words, especially when the child is excited, tired, or cognitively engaged. The absence of secondary physical behaviors (e.g., facial grimacing, eye blinking, physical tension) and the lack of frustration or avoidance behavior strongly distinguish this from true childhood-onset fluency disorder (stuttering). Because the symptoms have been present for less than 6 months and the child is otherwise developing well, the most appropriate management is to reassure the parents and observe the child's progress.

Step-by-Step Solution

1
Analyze the patient's age and symptom duration.
The patient is 3 years old with speech repetitions lasting 6 weeks.
Age of onset and symptom duration are critical for distinguishing normal developmental variants from pathological communication disorders.
2
Evaluate for the presence of secondary behaviors or distress.
The child shows no frustration, facial grimacing, or physical tension, and maintains good eye contact.
Secondary behaviors (motor tics, eye blinking, visible struggle) are hallmark signs of childhood-onset fluency disorder (stuttering) rather than normal disfluency.
3
Determine the appropriate management plan based on the clinical picture.
The presentation is classic for normal developmental disfluency.
Because the disfluency is recent, lacks secondary behaviors, and the child is otherwise developing normally, no medical or therapeutic intervention is warranted.

Key Concept

Differentiating normal developmental disfluency from childhood-onset fluency disorder (stuttering)
Question 744Question →

A 2828-year-old woman, who is at 1010 weeks gestation in her first pregnancy, presents to the psychiatric clinic with a 44-week history of overwhelming sadness, excessive sleeping up to 14 hours14\text{ hours} a day, and a sensation that her arms and legs are "weighed down by lead." She experiences daily crying spells and profound guilt over her lack of excitement regarding the pregnancy. She mentions that her primary care physician prescribed fluoxetine 33 weeks ago, but she discontinued it yesterday because she felt it was completely ineffective. Vital signs are within normal limits. Laboratory studies show a thyroid-stimulating hormone (TSH) level of 0.2 \muU/mL0.2\text{ \mu U/mL} (normal non-pregnant: 0.50.5-5.0 \muU/mL5.0\text{ \mu U/mL}) and a free thyroxine (T4) level of 1.1 ng/dL1.1\text{ ng/dL} (normal: 0.90.9-1.7 ng/dL1.7\text{ ng/dL}). Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Assess for a history of episodes characterized by racing thoughts and excessive energy

Answer

Assess for a history of episodes characterized by racing thoughts and excessive energy
This patient is experiencing a major depressive episode with atypical features (hypersomnia, leaden paralysis). A critical standard of care in psychiatry is to screen every patient presenting with depression for a past history of manic or hypomanic episodes before initiating antidepressant therapy. Atypical depressive features are highly correlated with bipolar depression. Prescribing antidepressant monotherapy to a patient with unrecognized bipolar disorder can precipitate a severe manic switch or rapid cycling.

Step-by-Step Solution

1
Analyze the patient's psychiatric presentation.
The patient meets criteria for a major depressive episode with atypical features (hypersomnia, leaden paralysis).
Establishing the current syndromic diagnosis guides the pharmacological approach.
2
Evaluate the patient's medication history.
The patient engaged in premature drug discontinuation of fluoxetine after only 33 weeks, which has a very long half-life.
Recognizing the short trial duration prevents incorrectly labeling the episode as treatment-resistant, and noting the specific drug (fluoxetine) informs future drug interaction risks.
3
Interpret the laboratory findings in the context of her pregnancy.
The mildly suppressed TSH with normal free T4 is a normal physiologic finding at 1010 weeks gestation due to hCG cross-reactivity.
This rules out an underlying endocrine pathology as the cause of her symptoms.
4
Determine the necessary diagnostic prerequisite before prescribing a new treatment.
The physician must screen for a history of mania or hypomania.
Antidepressant monotherapy in an unrecognized bipolar patient can precipitate a severe manic switch.

Key Concept

In patients presenting with a major depressive episode, particularly those with atypical features, screening for a history of manic or hypomanic episodes is a mandatory prerequisite before prescribing antidepressant therapy.
Estimated Time:1m 30s
Question 745Question →

A psychiatric consultation is requested for a 31-year-old male inpatient admitted to the medical intensive care unit. The patient was transferred from an outpatient psychiatric facility after developing severe muscle stiffness, diaphoresis, and altered mental status. He has a history of schizoaffective disorder and was recently prescribed fluphenazine. Current vital signs include a pulse of 115/min, blood pressure of 165/95 mmHg, and a temperature of 39.1°C (102.4°F). Physical examination reveals mutism and profound 'lead-pipe' rigidity. Laboratory evaluation reveals a significantly elevated serum creatine kinase level. The diagnosis of neuroleptic malignant syndrome (NMS) is established.

Arrange the following clinical interventions in the correct chronological sequence for managing this patient's condition, from the most immediate initial step to the final long-term management step.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for managing neuroleptic malignant syndrome is: 1) Discontinue the offending agent, 2) Initiate aggressive supportive care, 3) Administer targeted pharmacologic therapy for refractory/severe cases, and 4) Observe a minimum two-week washout period prior to antipsychotic rechallenge.
The standard of care for neuroleptic malignant syndrome strictly follows a sequence prioritizing the removal of the inciting agent, followed by physiological rescue via supportive care. Pharmacologic treatments (dopamine agonists like bromocriptine/amantadine, or ryanodine receptor antagonists like dantrolene) are reserved for cases that are severe or unresponsive to supportive measures. Finally, long-term management requires a mandatory waiting period of at least two weeks before any careful re-exposure to dopamine antagonists.

Step-by-Step Solution

1
Identify the primary cause of the life-threatening condition and remove it.
Discontinuation of fluphenazine.
Continuing the dopamine antagonist will exacerbate the central dopamine blockade driving the syndrome.
2
Stabilize the patient's acute physiological derangements.
Administration of intravenous fluids and cooling measures.
Rhabdomyolysis and severe hyperthermia can rapidly lead to acute renal failure and cardiovascular collapse without immediate supportive care.
3
Provide definitive medical therapy if supportive care is insufficient.
Administration of bromocriptine or dantrolene.
These agents directly counteract the dopamine blockade or muscle rigidity driving the hypermetabolic state in severe cases.
4
Plan for long-term psychiatric management after stabilization.
Two-week washout period before rechallenge.
Reintroducing antipsychotics too quickly carries a high risk of NMS recurrence; a two-week minimum ensures full clearance of the previous agent and physiological reset.

Key Concept

Stepwise clinical management algorithm for Neuroleptic Malignant Syndrome (NMS).
Estimated Time:1m 0s
Question 746Question →

Match each patient's clinical presentation to the psychological therapy that represents the most appropriate, evidence-based first-line treatment for their specific condition.

Click a left item, then click its matching right item

Items

A 22-year-old woman with a history of recurrent self-mutilation, intense affective instability, chronic feelings of emptiness, and frantic efforts to avoid abandonment.
A 45-year-old man with major depressive disorder triggered by a contentious divorce, currently struggling to adapt to his new role as a single father.
A 30-year-old woman with panic disorder who catastrophically misinterprets normal exercise-induced tachycardia as an impending myocardial infarction.
A 28-year-old man with obsessive-compulsive disorder who experiences intrusive images of a house fire and subsequently spends hours checking the stove.

Matches

Show answer & explanation

Answer

Patient 1 (Borderline Personality Disorder) matches with Dialectical Behavior Therapy. Patient 2 (Depression with Role Transition) matches with Interpersonal Psychotherapy. Patient 3 (Panic Disorder) matches with Cognitive-Behavioral Therapy. Patient 4 (Obsessive-Compulsive Disorder) matches with Exposure and Response Prevention.
Each psychiatric disorder has a preferred, evidence-based psychotherapeutic approach. Borderline personality disorder (affective instability, self-harm) is treated with DBT. Depression tied to major life changes (divorce, role transition) is treated with IPT. Panic disorder (catastrophizing physical symptoms) is treated with CBT. OCD (obsessions and compulsions) is treated with ERP.

Step-by-Step Solution

1
Diagnose the primary psychiatric condition for each patient based on their clinical vignette.
Patient 1 has Borderline Personality Disorder (BPD). Patient 2 has Major Depressive Disorder (MDD) linked to a significant life event. Patient 3 has Panic Disorder. Patient 4 has Obsessive-Compulsive Disorder (OCD).
Identifying the correct underlying diagnosis is a prerequisite to selecting the specific, evidence-based first-line psychological treatment.
2
Determine the first-line psychotherapy for Borderline Personality Disorder.
Dialectical behavior therapy (DBT) is the primary treatment.
DBT was specifically developed for BPD to reduce self-harm behaviors and improve emotion regulation through mindfulness and distress tolerance skills.
3
Determine the optimal psychotherapy for MDD heavily associated with a recent life change and relationship stress.
Interpersonal psychotherapy (IPT) is specifically indicated.
IPT is an evidence-based treatment for depression that focuses on role transitions, interpersonal disputes, and grief, making it ideal for this presentation.
4
Determine the optimal psychotherapy for Panic Disorder characterized by somatic misinterpretations.
Cognitive-behavioral therapy (CBT) is first-line.
CBT helps patients with panic disorder identify and systematically challenge their catastrophic misinterpretations of normal bodily sensations.
5
Determine the gold-standard psychotherapy for Obsessive-Compulsive Disorder.
Exposure and response prevention (ERP) is the specific modality required.
ERP breaks the cycle of OCD by deliberately exposing the patient to the anxiety-provoking obsession while strictly preventing the compensatory compulsion.

Key Concept

Selection of specific, evidence-based psychological therapies tailored to distinct psychiatric diagnoses and clinical presentations.
Question 747Question →

A 24-year-old man is brought to the emergency department by police after being found wandering in traffic. He is combative, completely disoriented, and screaming that he can fly. Physical examination reveals multidirectional nystagmus, tachycardia, and prominent diaphoresis. As the triage nurse approaches, the patient abruptly attempts to strike her. Arrange the following interventions in the most appropriate sequential order for the acute management of this patient's substance-induced agitation.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with attempting verbal de-escalation and ensuring environmental safety. When verbal de-escalation fails and the patient becomes actively violent, temporary physical restraints must be applied. This allows staff to safely administer an intramuscular benzodiazepine for rapid chemical sedation. Once the chemical sedation takes effect and the patient is calm, it is safe to perform a comprehensive physical examination, obtain vital signs, and draw blood. Finally, physical restraints should be discontinued, and the patient should be monitored in a low-stimulation setting.
The management of severe, substance-induced agitation (e.g., PCP intoxication) follows a strict protocol escalating from least to most restrictive interventions. Verbal de-escalation is always the first step. If the patient poses an immediate physical threat, physical restraints are necessary to secure the patient. Once secured, chemical restraints (intramuscular benzodiazepines) are administered to treat the underlying agitation. Medical assessments, including vital signs and blood draws (to check for rhabdomyolysis), can only be safely performed after the patient is chemically sedated. Finally, physical restraints must be removed as soon as they are no longer needed to prevent complications, and the patient is placed in a quiet environment to minimize sensory triggers.

Step-by-Step Solution

1
Prioritize immediate safety and attempt the least restrictive intervention.
Verbal de-escalation and environmental safety protocols are initiated.
Always start with the least restrictive means if possible, while protecting healthcare staff.
2
Address the imminent risk of physical harm when verbal methods fail.
Application of temporary physical restraints.
The patient is actively striking staff; physical control is strictly required before medications can be safely administered without causing needlestick injuries.
3
Treat the underlying severe agitation medically.
Intramuscular benzodiazepine administration.
Benzodiazepines provide rapid sedation and raise the seizure threshold, which is highly beneficial in phencyclidine (PCP) intoxication.
4
Evaluate for medical complications of the intoxication and agitation.
Physical exam, vital signs, and laboratory workup (e.g., creatine kinase).
Once sedated, checking for hyperthermia and rhabdomyolysis is critical. This cannot be safely done while the patient is combative.
5
Minimize ongoing restrictive measures and environmental triggers.
Removal of physical restraints and observation in a quiet room.
Restraints should be discontinued at the earliest possible time to prevent complications like skin breakdown or thrombosis. PCP intoxication is also exacerbated by sensory overload.

Key Concept

Sequential management of acute severe substance-induced agitation escalating from verbal de-escalation to physical and chemical restraints.
Estimated Time:1m 30s
Question 748Question →

A 4-year-old boy is brought to the pediatric clinic by his foster parents due to behavioral challenges at his preschool. His teacher notes that he frequently wanders the room during group storytime, flaps his hands repeatedly when excited, and avoids interacting with peers. At home, he meticulously sorts his blocks by shape and becomes inconsolable if the arrangement is disrupted. His foster parents report that he uses only two-word phrases to express his needs and rarely makes eye contact. On physical examination, the child successfully hops on one foot and copies a cross on a piece of paper. Which of the following statements regarding this patient are correct? (Select all that apply)

Select all that apply

Show answer & explanation

Answer: The patient's impaired social interaction and restricted, repetitive behaviors fulfill core diagnostic domains for autism spectrum disorder.; Early intensive behavioral and educational interventions are the most appropriate primary management strategy.

Answer

The correct statements recognize that the patient's presentation fulfills core diagnostic domains for autism spectrum disorder, and that early intensive behavioral and educational interventions are the primary management strategy.
This patient presents with classic features of autism spectrum disorder, which is characterized clinically by deficits in social communication and interaction, alongside restricted, repetitive patterns of behavior. Because these core deficits significantly impact functioning in multiple environments (school and home), early intensive behavioral interventions provide the most effective means to improve the patient's long-term social and communicative outcomes.

Step-by-Step Solution

1
Evaluate the patient's developmental milestones based on his chronological age of 4 years.
The patient's motor skills (hopping on one foot, copying a cross) are age-appropriate. His language skills (two-word phrases) are delayed, as a 4-year-old should typically be speaking in full sentences.
Establishing a developmental baseline differentiates normal development or global delays from specific neurodevelopmental disorders.
2
Analyze the behavioral symptoms presented in multiple settings (home and preschool).
The patient displays distinct deficits in social communication (poor eye contact, avoiding peers) and exhibits restricted, repetitive behaviors (hand-flapping, inflexible routines).
These two distinct domains form the required core diagnostic criteria for autism spectrum disorder.
3
Determine the most appropriate management plan for the identified condition.
Early intensive behavioral and educational intervention is indicated.
Behavioral therapies, such as applied behavior analysis, are the gold standard for improving adaptive functioning and communication in young children with this condition.

Key Concept

Autism spectrum disorder diagnosis and evaluation of pediatric developmental milestones
Estimated Time:1m 30s
Question 749Question →

A 29-year-old man presents to a community health center to establish primary care. He currently resides in a supported housing facility. During the clinical interview, the patient displays diminished emotional expression and speaks in a monotonous voice. When asked about his employment history, he states that he cannot hold a job because "foreign agents are constantly broadcasting their plans into my head." He reports that these experiences began shortly after his 22nd birthday and have been continuously present since that time. Upon detailed psychiatric history-taking, the patient mentions that three years ago, he felt profoundly sad, lacked energy, and slept for most of the day for a three-week period. He experienced a similar two-week episode of low mood last year. He has not experienced any other mood changes or periods of elevated energy. Physical examination, routine laboratory studies, and a urine toxicology screen are within normal limits. Based on the patient's history and presentation, which of the following is the most likely diagnosis?

Show answer & explanation

Answer: Schizophrenia

Answer

Schizophrenia
The correct diagnosis is schizophrenia. The patient exhibits characteristic symptoms of schizophrenia, including delusions (bizarre beliefs about foreign agents broadcasting plans) and negative symptoms (diminished emotional expression). To meet the diagnostic criteria for schizophrenia, continuous signs of the disturbance must be present for at least 6 months, which is clearly met by his 7-year continuous history. While the patient has experienced two distinct major depressive episodes, the total duration of these mood episodes (5 weeks) constitutes a very small minority of the total duration of his 7-year illness. Therefore, the mood episodes do not meet the threshold required for a diagnosis of schizoaffective disorder.

Step-by-Step Solution

1
Identify the primary psychotic symptoms and their duration.
The patient has delusions (thought broadcasting) and negative symptoms (diminished emotional expression, flattened affect) that have been continuously present for 7 years (since age 22).
Establishing the presence and total duration of Criterion A symptoms is necessary to differentiate among brief psychotic disorder, schizophreniform disorder, and schizophrenia.
2
Identify any concurrent mood symptoms and quantify their duration.
The patient had two brief depressive episodes lasting 3 weeks and 2 weeks, totaling 5 weeks of mood symptoms over a 7-year period.
Evaluating the temporal relationship and relative duration of mood symptoms to psychotic symptoms differentiates primary psychotic disorders from schizoaffective disorder and mood disorders with psychotic features.
3
Synthesize the timeline to determine the final diagnosis.
Psychosis duration is greater than 6 months (ruling out brief psychotic disorder and schizophreniform). Psychosis occurs outside of mood episodes (ruling out MDD with psychotic features). Mood episodes are not present for a majority of the illness duration (ruling out schizoaffective disorder).
Applying DSM-5 criteria logically eliminates competing diagnoses on the differential spectrum.

Key Concept

To diagnose schizophrenia, continuous signs of the disturbance must persist for at least 6 months. If major depressive or manic episodes occur alongside active-phase symptoms, they must be present for only a minority of the total duration of the active and residual periods of the illness; otherwise, a diagnosis of schizoaffective disorder is warranted.
Estimated Time:1m 15s
Question 750Question →

A 24-year-old medical student is diagnosed with a first episode of major depressive disorder. After ruling out any history of mania or hypomania, the physician prescribes a selective serotonin reuptake inhibitor (SSRI). The physician provides comprehensive anticipatory guidance regarding the expected treatment timeline. Arrange the following clinical events in the standard chronological order of their expected occurrence during a successful, uncomplicated course of SSRI therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence of events during SSRI therapy is: 1) Onset of transient adverse effects, 2) Improvement in neurovegetative symptoms, 3) Improvement in subjective mood, 4) Achievement of maximal therapeutic benefit, and 5) Initiation of a gradual taper after at least 6 months of remission.
The timeline of SSRI therapy follows a highly predictable clinical course. Initially, the acute increase in synaptic serotonin causes side effects (e.g., gastrointestinal distress, agitation) within hours to days. By weeks 1 to 2, neurovegetative symptoms such as sleep, appetite, and energy begin to improve. By weeks 4 to 6, neuroplastic changes and the downregulation of inhibitory autoreceptors lead to an improvement in subjective mood and anhedonia. Full remission may take 8 to 12 weeks to achieve. Once remission is achieved, clinical guidelines mandate a 'continuation phase' of at least 6 months for a first depressive episode before any gradual tapering is initiated to minimize the risk of relapse.

Step-by-Step Solution

1
Identify the immediate physiologic response to SSRI initiation.
Side effects such as GI distress and jitteriness occur in the first few days.
Immediate increases in synaptic serotonin affect peripheral and central nervous system receptors prior to any adaptive downregulation.
2
Determine the first domain of clinical improvement.
Neurovegetative symptoms (energy, sleep, appetite) improve during weeks 1 to 2.
Physical symptoms respond faster than cognitive/emotional symptoms. This mismatch can lead to a transient increase in suicide risk as energy returns before mood improves.
3
Establish the timeline for subjective emotional improvement.
Subjective mood and anhedonia improve during weeks 4 to 6.
Emotional regulation requires long-term neurobiological adaptations, including autoreceptor downregulation and increased brain-derived neurotrophic factor (BDNF) expression.
4
Recognize the peak of the treatment response.
Full remission and maximal therapeutic benefit are achieved between weeks 8 and 12.
Some patients require extended time at a therapeutic dose to reach complete remission.
5
Apply standard guidelines for the discontinuation of therapy.
A taper is initiated only after a 6-month continuation phase.
Continuing medication for 6 to 9 months after remission of a first episode is standard of care to prevent early relapse.

Key Concept

The typical clinical timeline of SSRI response and treatment phases in Major Depressive Disorder.
Question 751Question →

A 38-year-old man is brought to the emergency department by his husband due to a sudden, severe, pounding headache, blurred vision, and chest palpitations. The symptoms began approximately 45 minutes ago. The patient has a history of severe, treatment-resistant major depressive disorder. He recently started a new psychiatric medication after trials of several selective serotonin reuptake inhibitors and a serotonin-norepinephrine reuptake inhibitor failed to improve his mood. Earlier this evening, he attended a holiday party where he consumed multiple glasses of tap beer, aged cheddar cheese, and cured sausages. His temperature is 37.2°C (99.0°F), blood pressure is 218/124 mm Hg, pulse is 122/min, and respirations are 18/min. Physical examination reveals a diaphoretic and tremulous man. Neurological examination shows no focal deficits, and an unenhanced head CT scan reveals no abnormalities. Which of the following medications is this patient most likely taking?

Show answer & explanation

Answer: Tranylcypromine

Answer

Tranylcypromine
The correct answer is tranylcypromine, which is a nonselective monoamine oxidase inhibitor (MAOI). MAOIs (such as tranylcypromine, phenelzine, and isocarboxazid) are highly effective but are typically reserved for treatment-resistant major depressive disorder or atypical depression due to their severe side effect profile and dietary restrictions. Monoamine oxidase-A (MAO-A) in the gastrointestinal tract and liver is responsible for breaking down dietary tyramine, a naturally occurring sympathomimetic amine found in aged cheeses, cured and smoked meats, fermented products, and tap beer. When a patient taking an MAOI consumes these tyramine-rich foods, the un-metabolized tyramine enters the systemic circulation and is taken up by sympathetic nerve terminals. Once inside, it displaces massive amounts of stored norepinephrine from presynaptic vesicles into the synaptic cleft. This sudden surge of catecholamines causes severe alpha-1 adrenergic receptor stimulation, resulting in widespread vasoconstriction and an acute hypertensive crisis. Patients classically present with a sudden severe headache, blurred vision, palpitations, diaphoresis, and dangerously elevated blood pressure. Immediate treatment with an alpha-adrenergic antagonist, such as phentolamine, is often required.

Step-by-Step Solution

1
Evaluate the patient's acute clinical presentation and vital signs.
The patient presents with a severe headache, palpitations, diaphoresis, and severe hypertension (blood pressure 218/124 mm Hg).
Identifying a hypertensive emergency with target organ symptoms (headache, blurred vision) is the first step in determining the underlying etiology.
2
Analyze the patient's psychiatric history and activities prior to symptom onset.
The patient recently started a new medication for treatment-resistant depression and consumed tap beer, aged cheese, and cured meats just before the onset of symptoms.
Connecting the dietary intake of tyramine-rich foods to the onset of the hypertensive crisis narrows the differential diagnosis to a specific drug-diet interaction.
3
Identify the psychiatric medication class associated with this specific dietary interaction.
Monoamine oxidase inhibitors (MAOIs) prevent the gastrointestinal breakdown of dietary tyramine, leading to a profound sympathetic surge.
Tyramine is a sympathomimetic amine that displaces norepinephrine from presynaptic vesicles when its metabolism by MAO-A is inhibited.
4
Select the MAOI from the given pharmacological options.
Tranylcypromine is the only MAOI listed among the options.
Recognizing the specific generic names of MAOIs is required to determine the correct medication causing this patient's crisis.

Key Concept

MAOI-induced hypertensive crisis triggered by tyramine-rich foods
Question 752Question →

A 34-year-old man with treatment-resistant schizophrenia is brought to the emergency department by his partner after experiencing a generalized tonic-clonic seizure lasting approximately 2 minutes. He has no prior history of seizures. His psychotic symptoms have been well controlled on a stable regimen of clozapine 400 mg daily for the past 3 years. Four weeks ago, the patient suffered an uncomplicated myocardial infarction and was discharged on aspirin and atorvastatin. At that time, the patient successfully quit smoking cold turkey after previously smoking 2 packs of cigarettes daily for 15 years. He reports no illicit drug or alcohol use. His temperature is 37.1°C (98.8°F), blood pressure is 118/76 mm Hg, pulse is 88/min, and respirations are 16/min. Physical examination reveals a postictal state but is otherwise unremarkable. Laboratory studies show an absolute neutrophil count of 5,200/mm35,200/mm^3 and normal liver function tests. Which of the following is the most likely mechanism responsible for this patient's new-onset seizure?

Show answer & explanation

Answer: Decreased induction of a hepatic cytochrome P450 enzyme

Answer

Decreased induction of a hepatic cytochrome P450 enzyme
The correct answer identifies the loss of cytochrome P450 enzyme induction as the cause of the seizure. Polycyclic aromatic hydrocarbons present in tobacco smoke are potent inducers of CYP1A2, the primary hepatic enzyme responsible for metabolizing clozapine. When a patient who is stabilized on clozapine abruptly stops smoking, the induction of CYP1A2 is lost. This leads to a rapid decrease in clozapine clearance and a subsequent elevation in serum clozapine levels. Clozapine is well known to lower the seizure threshold in a dose-dependent manner. The sudden, drastic increase in clozapine concentration precipitated this patient's new-onset generalized tonic-clonic seizure.

Step-by-Step Solution

1
Identify the patient's baseline medications and recent lifestyle changes.
The patient is on a high but stable dose of clozapine and recently underwent abrupt smoking cessation following a myocardial infarction.
Clozapine relies heavily on specific metabolic pathways that are influenced by environmental factors.
2
Determine the metabolic interaction between tobacco smoke and clozapine.
Polycyclic aromatic hydrocarbons in tobacco smoke are potent inducers of the hepatic enzyme cytochrome P450 1A2 (CYP1A2), which is the primary enzyme responsible for clozapine metabolism.
Understanding the enzyme system involved explains how the patient's medication levels are altered.
3
Analyze the physiological effect of smoking cessation on clozapine levels.
Abrupt smoking cessation removes the CYP1A2 induction, causing a relative decrease in enzyme activity. This leads to reduced clozapine clearance and a significant rise in serum clozapine levels.
This establishes the mechanism for medication toxicity.
4
Correlate the elevated clozapine levels with the clinical presentation.
Clozapine has a known, dose-dependent risk of causing seizures. The abrupt rise in serum clozapine resulting from the loss of CYP1A2 induction precipitated the tonic-clonic seizure.
This confirms that the physiological change directly caused the patient's symptom.

Key Concept

Polycyclic aromatic hydrocarbons in tobacco smoke strongly induce cytochrome P450 1A2 (CYP1A2). Abrupt smoking cessation in a patient on clozapine (a CYP1A2 substrate) removes this induction, leading to elevated clozapine levels and an increased risk of dose-dependent toxicities, such as seizures.
Estimated Time:1m 30s
Question 753Question →

Match each clinical presentation with the most likely definitive psychiatric diagnosis.

Click a left item, then click its matching right item

Items

A 27-year-old woman exhibits auditory hallucinations and disorganized speech for 2 weeks following a severe psychological stressor, followed by a full return to her premorbid level of functioning.
A 22-year-old man presents with a 4-month history of worsening social withdrawal, avolition, and persistent delusions of reference regarding television broadcasts.
A 31-year-old man with a 2-year history of prominent auditory hallucinations develops an episode of major depression. His psychotic symptoms persist even during periods of normal mood.
A 45-year-old woman has firmly believed for the past year that her neighbor is plotting to sabotage her garden. She functions normally at her job and has no disorganized behavior or hallucinations.

Matches

Show answer & explanation

Answer

The correct matches are based on symptom duration and the relationship between mood and psychotic symptoms: Brief psychotic disorder (<1 month), Schizophreniform disorder (1-6 months), Schizoaffective disorder (psychosis independent of mood episodes), and Delusional disorder (isolated delusions).
Each psychiatric diagnosis is defined by specific temporal and symptomatic criteria as established in the DSM-5. Brief psychotic disorder is characterized by symptoms lasting less than 1 month with full recovery. Schizophreniform disorder requires symptoms lasting between 1 and 6 months. Schizoaffective disorder requires a major mood episode concurrent with active-phase psychotic symptoms, plus a distinct period of at least 2 weeks of delusions or hallucinations without prominent mood symptoms. Delusional disorder involves at least 1 month of delusions without meeting criteria for schizophrenia, and functioning is not markedly impaired.

Step-by-Step Solution

1
Evaluate the duration of psychotic symptoms for each patient.
The patients have symptoms lasting 2 weeks, 4 months, 2 years, and 1 year, respectively.
Duration is the primary diagnostic differentiator for brief psychotic disorder (<1 month), schizophreniform disorder (1-6 months), and schizophrenia (>6 months).
2
Assess the temporal relationship between mood symptoms and psychosis.
The patient with a 2-year history of hallucinations maintains these symptoms even when not depressed.
Psychosis occurring for >2 weeks without concurrent mood symptoms rules out a major mood disorder with psychotic features, confirming schizoaffective disorder.
3
Determine the breadth of symptoms and level of functional impairment.
The 45-year-old woman has an isolated false belief without negative symptoms or global dysfunction.
Isolated delusions without other psychotic features or marked functional decline are the hallmark of delusional disorder.

Key Concept

Differentiating primary psychotic disorders based on symptom duration, symptom cluster, and the temporal relationship between mood episodes and psychosis.
Question 754Question →

A 6565-year-old retired firefighter is brought to the outpatient clinic by his husband. For the past 55 weeks, the patient has experienced a pervasive low mood, early morning awakenings, and a lack of interest in his previously beloved woodworking projects. He has lost 55 kg (1111 lb) during this period. The symptoms started roughly 22 weeks after he suffered an uncomplicated myocardial infarction. He says, "My life is essentially over; there is nothing to look forward to." Past medical history includes hypertension and the recent myocardial infarction. Thirty-five years ago, he experienced an episode of paranoia and auditory hallucinations that lasted for 1414 days and resolved completely without any subsequent psychotic symptoms. Current medications include aspirin, ticagrelor, metoprolol, rosuvastatin, and linezolid, which was started 44 days ago for a methicillin-resistant Staphylococcus aureus skin infection. The patient's advance directive designates his sister as his healthcare proxy. He is alert, oriented, and demonstrates a clear understanding of his diagnosis and treatment options. His husband pulls the physician aside and says, "He is too sad to think straight; I am his spouse, so I authorize you to prescribe whatever strong medication he needs right now." The physician concludes that the patient is experiencing a major depressive episode. Which of the following is the most appropriate next step in management?

Show answer & explanation

Answer: Inquire about prior episodes characterized by unusually high energy, grandiosity, and reduced sleep

Answer

Inquire about prior episodes characterized by unusually high energy, grandiosity, and reduced sleep
Before initiating antidepressant monotherapy for a major depressive episode, it is critical to rule out a history of bipolar disorder. Unopposed antidepressants (such as SSRIs) can precipitate a manic or hypomanic episode in patients with bipolar depression. Therefore, the physician must inquire about prior episodes of elevated mood, impulsivity, and decreased need for sleep to ensure safe pharmacotherapy.

Step-by-Step Solution

1
Evaluate the patient's presenting symptoms and timeline.
The patient meets the diagnostic criteria for a major depressive episode (depressed mood, anhedonia, weight loss, insomnia) lasting more than 22 weeks.
To establish the primary psychiatric syndrome requiring intervention.
2
Review the patient's past psychiatric history and current medication list.
The history reveals a resolved brief psychotic disorder and current linezolid use, but no documented screening for bipolar disorder.
To identify contraindications or necessary prerequisites before starting pharmacotherapy.
3
Determine the safest next clinical action before initiating standard depression treatment.
Screening for past hypomanic or manic episodes must be performed to differentiate unipolar from bipolar depression.
Antidepressant monotherapy in bipolar depression can induce a dangerous manic switch.

Key Concept

All patients presenting with a major depressive episode must be carefully screened for a history of mania or hypomania to rule out bipolar disorder before initiating unopposed antidepressant therapy.
Estimated Time:1m 30s
Question 755Question →

Match each of the following substance withdrawal syndromes with its most characteristic clinical presentation.

Click a left item, then click its matching right item

Items

Opioid withdrawal
Cocaine withdrawal
Cannabis withdrawal
Nicotine withdrawal
Severe alcohol withdrawal

Matches

Show answer & explanation

Answer

Opioid withdrawal pairs with yawning/piloerection; Cocaine withdrawal pairs with hypersomnolence/hyperphagia; Cannabis withdrawal pairs with irritability/decreased appetite; Nicotine withdrawal pairs with intense cravings/weight gain; Severe alcohol withdrawal pairs with fluctuating sensorium/autonomic hyperactivity.
Each substance withdrawal syndrome is accurately paired with its classic constellation of symptoms based on DSM-5 criteria and standard clinical presentation. Withdrawal symptoms generally represent a homeostatic rebound; for instance, the withdrawal of a stimulant (cocaine) leads to lethargy and hypersomnolence, while the withdrawal of a depressant (alcohol) leads to dangerous autonomic hyperactivity and delirium. Specific signs like piloerection and yawning are highly specific to opioid withdrawal.

Step-by-Step Solution

1
Identify the characteristic physiological signs of opioid withdrawal.
Opioid withdrawal is matched to yawning, piloerection, rhinorrhea, and hyperactive bowel sounds.
Opioid withdrawal uniquely features piloerection ('cold turkey') and severe flu-like symptoms without life-threatening autonomic instability.
2
Identify the 'crash' phase symptoms associated with stimulant withdrawal.
Cocaine withdrawal is matched to profound dysphoria, hypersomnolence, and hyperphagia.
Stimulant withdrawal causes a rebound effect characterized by extreme fatigue, increased appetite, and depression, contrasting with the hyperactivity of intoxication.
3
Differentiate between the behavioral symptoms of cannabis and nicotine withdrawal.
Cannabis withdrawal is matched to irritability, insomnia, and decreased appetite. Nicotine withdrawal is matched to cravings, difficulty concentrating, and increased appetite.
While both cause irritability, cannabis withdrawal characteristically causes decreased appetite, whereas nicotine withdrawal typically leads to increased appetite and weight gain.
4
Identify the timeline and severity of complicated alcohol withdrawal.
Severe alcohol withdrawal is matched to fluctuating sensorium, visual hallucinations, and marked autonomic hyperactivity 48-96 hours after cessation.
Delirium tremens is a specific, severe manifestation of alcohol withdrawal occurring late in the withdrawal timeline.

Key Concept

The clinical presentation of substance withdrawal syndromes typically represents a rebound effect, manifesting as the physiological opposite of the substance's acute intoxication effects.
Question 756Question →

Match each patient's clinical presentation with the most appropriate initial pharmacological intervention.

Click a left item, then click its matching right item

Items

A 78-year-old woman with a 6-week history of depressed mood, profound insomnia, and an unintentional 4-kg (8.8-lb) weight loss.
A 55-year-old man with a 2-month history of anhedonia, low mood, and severe bilateral burning foot pain due to long-standing diabetes mellitus.
A 34-year-old woman with a 3-month history of depressed mood, profound fatigue, and weight gain, who explicitly requests a treatment that will not cause sexual dysfunction.
A 45-year-old man with a 4-week history of severe depression, psychomotor retardation, and a fixed belief that his internal organs are rotting.

Matches

Show answer & explanation

Answer

The 78-year-old woman with insomnia/weight loss matches with mirtazapine. The 55-year-old man with diabetic neuropathy matches with duloxetine. The 34-year-old woman avoiding sexual dysfunction matches with bupropion. The 45-year-old man with somatic delusions matches with sertraline and olanzapine.
The correct matches align the unique pharmacologic profiles (including mechanism of action and common adverse effects) of specific medications with each patient's clinical needs. Mirtazapine provides targeted relief for insomnia and anorexia. Duloxetine addresses both mood and neuropathic pain. Bupropion avoids sexual side effects while mitigating fatigue. A combination of an antidepressant and antipsychotic is mandated for psychotic depression.

Step-by-Step Solution

1
Analyze the 78-year-old woman's symptom cluster.
Identify prominent insomnia and weight loss in the setting of depression.
Mirtazapine is uniquely suited for this profile due to its side effects of appetite stimulation and sedation.
2
Analyze the 55-year-old man's comorbidities.
Identify concurrent major depressive disorder and painful diabetic neuropathy.
SNRIs like duloxetine offer dual efficacy, treating both the psychiatric and neurologic symptoms simultaneously.
3
Analyze the 34-year-old woman's treatment preferences and symptoms.
Identify fatigue, weight gain, and a strong desire to avoid sexual side effects.
Bupropion avoids the sexual dysfunction and weight gain typically seen with SSRIs, and provides an activating effect.
4
Analyze the 45-year-old man's clinical presentation.
Identify the presence of delusions (rotting organs), indicating major depressive disorder with psychotic features.
Antidepressant monotherapy is insufficient; standard management requires combining an antidepressant with an antipsychotic.

Key Concept

Tailoring pharmacotherapy for major depressive disorder based on patient-specific symptom clusters, medical comorbidities, and desired side-effect profiles.
Estimated Time:1m 30s
Question 757Question →

A 35-year-old man with a history of schizoaffective disorder is admitted to the inpatient psychiatric unit due to an acute exacerbation of psychotic symptoms. He is started on fluphenazine. Three days later, the nursing staff finds him confused and diaphoretic. Vital signs show a temperature of 39.5°C (103.1°F), blood pressure of 160/100 mmHg, and heart rate of 122/min. Physical examination reveals profound lead-pipe muscle rigidity. Laboratory studies demonstrate a markedly elevated serum creatine kinase (CK) level and leukocytosis. Arrange the following steps in the management of this patient's current condition in the most appropriate sequential order, from the initial, most critical action to treatments reserved for refractory cases.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequential order for managing neuroleptic malignant syndrome (NMS) is: 1) Discontinue the antipsychotic, 2) Initiate supportive care, 3) Administer targeted pharmacotherapy, 4) Consider ECT.
The correct management of neuroleptic malignant syndrome requires a prompt, stepwise approach. The definitive first step is stopping the offending dopamine antagonist. Next, because NMS causes massive metabolic derangements and risks acute kidney injury from rhabdomyolysis, aggressive supportive care with IV fluids and cooling is instituted. For moderate to severe cases not responding quickly to supportive care, targeted medications like dopamine agonists (bromocriptine) or muscle relaxants (dantrolene) are used. Finally, in the most severe, treatment-resistant cases, electroconvulsive therapy (ECT) is highly effective and represents the final step of the protocol.

Step-by-Step Solution

1
Identify the patient's diagnosis based on the clinical presentation.
The patient has altered mental status, autonomic instability, lead-pipe rigidity, and elevated CK after starting fluphenazine, which strongly indicates neuroleptic malignant syndrome (NMS).
Recognizing NMS is a critical first step, as it is a life-threatening psychiatric emergency requiring an immediate, stepwise intervention.
2
Determine the initial and most critical step in management.
The first step is to immediately stop the offending agent (fluphenazine).
NMS is triggered by dopamine antagonism; continued exposure will worsen the condition and increase mortality.
3
Identify the next standard line of treatment after removing the trigger.
Initiate intensive supportive care (IV fluids, cooling).
Supportive care prevents the most common causes of mortality in NMS, such as acute kidney injury from rhabdomyolysis and complications from hyperthermia.
4
Determine the interventions for cases that do not resolve with initial measures.
Administer medications like bromocriptine or dantrolene, and if still refractory, proceed to ECT.
Targeted medications help reverse the dopamine blockade and muscle rigidity. ECT is highly effective but invasive, making it appropriate for refractory, severe cases.

Key Concept

Neuroleptic Malignant Syndrome (NMS) Management Sequence

Alternative Method

A helpful mnemonic for the clinical signs of NMS is 'FALTER': Fever, Autonomic instability, Leukocytosis, Tremor, Elevated CK, Rigidity (lead-pipe). The management strictly follows a progressive escalation based on symptom severity: Stop drug -> Support -> Medicate -> ECT.
Estimated Time:1m 0s
Question 758Question →

A 32-year-old woman comes to the clinic seeking help to stop drinking alcohol. She reports drinking 1 to 2 bottles of wine every evening for the past year. She tried to quit two days ago but experienced severe cravings, anxiety, and mild tremors, leading her to resume drinking. She also reports feeling severely depressed, with low energy, poor concentration, and feelings of worthlessness for the past month. Her psychiatric history is notable for a hospitalization three years ago due to an episode of severe agitation, rapid pressured speech, grandiosity, and a lack of need for sleep lasting 10 days. Her medical history includes chronic low back pain, for which she takes tramadol on an as-needed basis; she last took a dose this morning. Physical examination and laboratory studies, including liver function tests and serum creatinine, are within normal limits. Which of the following is the most appropriate pharmacotherapy regimen for this patient?

Show answer & explanation

Answer: Quetiapine and acamprosate

Answer

The most appropriate regimen is quetiapine and acamprosate.
The correct combination pairs an atypical antipsychotic (quetiapine) with an NMDA receptor modulator (acamprosate). Quetiapine is FDA-approved for acute bipolar depression and avoids the risk of precipitating mania associated with standard antidepressants. Acamprosate is a first-line treatment for Alcohol Use Disorder that helps maintain abstinence. Because acamprosate does not act on opioid receptors, it is safe to use in a patient taking tramadol. Furthermore, her normal serum creatinine indicates no contraindication to acamprosate, which is renally excreted.

Step-by-Step Solution

1
Diagnose the patient's mood disorder and identify safe pharmacotherapy.
The patient has Bipolar I Disorder currently in a depressive episode. Atypical antipsychotics like quetiapine or lurasidone are indicated, while SSRI monotherapy must be avoided.
The history of a 10-day hospitalization for grandiosity and decreased need for sleep indicates a past manic episode. Antidepressant monotherapy can precipitate a manic switch.
2
Diagnose the substance use disorder and identify concurrent medications.
The patient has severe Alcohol Use Disorder (AUD) and is actively taking tramadol (an opioid) for chronic pain.
Recognizing concurrent opioid use is critical for selecting safe AUD pharmacotherapy.
3
Select the appropriate AUD medication that avoids drug-drug interactions.
Acamprosate is the safest choice. Naltrexone is contraindicated due to tramadol use, and disulfiram is unsafe given her active drinking status.
Naltrexone is a mu-opioid antagonist and will precipitate severe withdrawal if given to a patient taking opioids. Acamprosate is safely metabolized via the kidneys and does not interact with opioids.

Key Concept

Pharmacological management of concurrent Alcohol Use Disorder and Bipolar I depression, emphasizing the avoidance of SSRI monotherapy and contraindications of naltrexone in patients taking opioids.
Question 759Question →

A 24-year-old man is diagnosed with schizophrenia after presenting with a 7-month history of auditory hallucinations and persecutory delusions. His psychiatrist is planning a long-term pharmacotherapy strategy. Assuming the patient exhibits an inadequate clinical response to each consecutive intervention despite optimal dosing and confirmed medication adherence, arrange the following treatment steps in the correct standard algorithm for the management of schizophrenia.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence begins with a first-line antipsychotic, followed by an alternative first-line agent, then clozapine for treatment resistance, and finally clozapine augmentation.
The standard treatment algorithm for schizophrenia dictates that patients begin with a first-line antipsychotic. If the first trial fails due to lack of efficacy or intolerability, a different first-line antipsychotic should be tried. Only after two adequate trials of different antipsychotics fail is a patient diagnosed with treatment-resistant schizophrenia, for which clozapine is the gold standard. If clozapine monotherapy is insufficient, augmentation with ECT or another agent is the final step.

Step-by-Step Solution

1
Identify the first step in pharmacological management for a newly diagnosed patient with schizophrenia.
Initiate a trial of a first-line second-generation antipsychotic (e.g., risperidone).
Second-generation antipsychotics are the preferred initial treatment due to a lower risk of extrapyramidal symptoms compared to first-generation agents.
2
Determine the next management step following a single failed adequate medication trial.
Switch to a trial of an alternative first-line antipsychotic (e.g., aripiprazole).
Treatment-resistant schizophrenia requires the failure of at least two antipsychotics. Therefore, a second trial with a different standard agent is indicated before moving to clozapine.
3
Identify the threshold and treatment for treatment-resistant schizophrenia.
Initiate a trial of clozapine with absolute neutrophil count (ANC) monitoring.
After failing two adequate trials of different antipsychotics, the patient is considered treatment-resistant. Clozapine is the only evidence-based medication for this stage.
4
Determine the strategy for a patient who has an inadequate response to optimized clozapine monotherapy.
Augment clozapine with an additional agent (e.g., electroconvulsive therapy or a second antipsychotic).
If clozapine monotherapy fails, augmentation strategies such as adding a second antipsychotic, a mood stabilizer, or electroconvulsive therapy (ECT) are employed.

Key Concept

The pharmacological treatment algorithm for schizophrenia progresses from a first-line antipsychotic to an alternative first-line antipsychotic, followed by clozapine (after two failed trials), and finally clozapine augmentation.
Estimated Time:1m 30s
Question 760Question →

A university student, aged 22, presents to the campus health center complaining of an 8-week history of profound melancholy, excessive sleepiness, and a complete inability to concentrate. She explains that she has stopped attending her lectures and feels devoid of any motivation. Review of her medical records reveals a prior psychiatric admission two years ago; during that time, she remained awake for six consecutive days, exhibited grandiose delusions about leading the university, and engaged in highly disruptive activities on campus before being hospitalized. She is currently not taking any medications. Recent thyroid function tests show a thyroid-stimulating hormone (TSH) level of 2.5μU/mL2.5 \mu\text{U/mL} (normal: 0.4−4.0μU/mL0.4-4.0 \mu\text{U/mL}) and a free thyroxine (T4T_4) level of 0.9 ng/dL0.9 \text{ ng/dL} (normal: 0.8−1.8 ng/dL0.8-1.8 \text{ ng/dL}). She insists on being prescribed a medication to lift her mood so she can return to her studies. Which of the following is the most appropriate management plan for this patient?

Show answer & explanation

Answer: Commence therapy with quetiapine

Answer

Commence therapy with quetiapine
The patient is currently presenting with a major depressive episode. However, her history of an episode characterized by decreased need for sleep, grandiosity, and hospitalization lasting six days unequivocally establishes a diagnosis of bipolar I disorder. The first-line pharmacological treatment for bipolar depression includes specific atypical antipsychotics (such as quetiapine or lurasidone) or mood stabilizers (such as lithium or lamotrigine). Quetiapine effectively treats the depressive symptoms without carrying the high risk of inducing a manic switch that is associated with standard antidepressants.

Step-by-Step Solution

1
Analyze the patient's current symptoms and duration.
The patient is experiencing a major depressive episode, characterized by 8 weeks of profound low mood, hypersomnia, and impaired concentration.
Establishing the current clinical syndrome is the first step in formulating a differential diagnosis.
2
Review the patient's past medical and psychiatric history.
The patient has a history of a discrete episode involving grandiosity, severe insomnia without fatigue, and disruptive behavior requiring hospitalization.
This historical event meets the full criteria for a manic episode, which changes the diagnosis from major depressive disorder to bipolar I disorder.
3
Evaluate the laboratory findings provided.
Both the TSH and free T4 levels fall within their respective normal reference ranges.
Normal thyroid function rules out an underlying endocrine etiology (such as hypothyroidism) for her depressive symptoms.
4
Select the safest and most effective pharmacotherapy for the established diagnosis.
Select an agent approved for bipolar depression, such as the atypical antipsychotic quetiapine.
In bipolar depression, standard antidepressant monotherapy must be avoided due to the risk of precipitating a manic switch. Mood stabilizers or specific atypical antipsychotics are indicated.

Key Concept

When evaluating a patient presenting with a major depressive episode, clinicians must meticulously screen for a history of mania or hypomania; the presence of a past manic episode confirms bipolar I disorder, requiring treatment with specific atypical antipsychotics or mood stabilizers rather than antidepressant monotherapy.
PreviousPage 38 / 41Next
Psychiatry Practice Questions — USMLE Step 2 CK — Page 38 | Examkin